Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀

cardiovascular

1. Angiotensin-converting enzyme (ACE) inhibitors :Introduction to the Use of ACE Inhibitors in Controlling Cardiovascular Disease
2. Hypertension Screening : Introduction to USPSTF Hypertension Screening Recommendations
3.Abdominal aortic aneurysm
4.Acute chest pain
5.Acute Coronary Syndromes
6.Acute myocardial infarction
7.Angina : Investigations for Suspected Angina
8.Antihypertensive drug therapy choice – NICE guidance
9.Antiplatelet treatment
10.Aortic Stenosis
11.Aortic valve disease : guidance on referral NICE
12.Atrial fibrillation – NICE guidance April 2021
13.Atrial Fibrillation-basics
14.Atrial flutter
15.Atrial Septal Defects ( ASD )
16.Atrioventricular heart blocks
17.Bradycardia : approach to assessment and management in primary care
18.Cardiac arrhythmias-an overview
19.Cardiomyopathy
20.Cardiovascular disease: risk assessment and reduction, including lipid modification ( NICE Update summary December 2023 )
21.CHA2DS2VASc score tool -Anticoagulation therapy
22.Chronic Heart Failure- NICE guidance
23.Dapagliflozin in Chronic Heart Failure : NICE guidance summary
24.Deep Vein Thrombosis ( DVT )
25.ECG : P waves
26.ECG : Q Wave
27.ECG : Step-by-Step Guide to Assessing Cardiac Rhythm
28.ECG : Step-by-Step Guide to Calculating Heart Rate from ECG at Standard 25 mm s
29.ECG : The Axis
30.ECG : The PR Interval
31.ECG Basics
32.Empagliflozin in Chronic Heart Failure : NICE recommendations
33.Familial hypercholesterolaemia
34.Familial hypercholesterolaemia in adults : management summary CKS NICE
35.Fibrates for CVD prevention; NICE
36.HAS-BLED Bleeding risk tool
37.Heart valve disease : Guidelines for Referral for Echocardiography and Specialist Assessment in Adults with Suspected Valve Disease
38.Heart failure : management and monitoring NICE summary
39.Heart failure diagnosis : role and significance of B-type natriuretic peptide (BNP)
40.Heart rhythm : Methods of Event Recording in Cardiology for Assessing Heart Rhythm
41.Hypertension : Antihypertensive drug treatment (NICE Guidance )
42.Hypertension : Clinic Blood Pressure Targets ( NICE )
43.Hypertension : diagnosis NICE
44.Hypertension : NICE guidance November 2023 Key Updates
45.Hypertension : who to refer for same day assessment NICE
46.Hypertension in adults
47.Hypertension management : ACC-AHA guideline summary
48.Hypertensive crises
49.Hypertrophic Obstructive Cardiomyopathy.
50.Inclisiran : Indications and use
51.Infective Endocarditis : NICE guidance on Risk and Prophylaxis ( Summarised )
52.Irregular Pulse : approach in primary care
53.Left Bundle Branch Block
54.Lipid modification therapy
55.Lipid Modification Therapy : Follow up
56.Lipid profile ( Cholesterol test ) : Key concepts
57.Lipoprotein(a): Understanding Its Role and Impact in Cardiovascular Health
58.Mitral stenosis
59.Myocardial Damage : Biochemical markers
60.Myocardial infarction : drugs for secondary prevention
61.Myocarditis : an overview for the primary care clinician
62.NOACS-Apixaban
63.Orbit bleeding tool
64.Orthostatic hypotension
65.Palpitations
66.Palpitations : Initial work up and further investigations
67.Palpitations : management guidance when to refer ( summary NICE )
68.Patent Ductus Arteriosus
69.Peripheral arterial disease
70.Pulmonary Embolism
71.QRISK model : CVD risk
72.QT Interval
73.Right bundle branch block
74.Secondary hypertension
75.SGLT-2 Inhibitors in Heart Failure
76.Stable angina -assessment and diagnosis
77.Stable angina -basics
78.Stable Angina Management
79.Statin intolerance pathway
80.Statin Use for Primary Prevention of Cardiovascular Disease: USPSTF guidance summary
81.Statins : adverse effects and intolerance management NICE
82.Syncope :assessment and management in primary care
83.Tachycardia : Causes and initial workup
84.Triglycerides elevated : management summary NICE
85.Ventricular Septal Defect ( VSD )
86.Warfarin duration of treatment
87.Warfarin-High INR